Pain Control in Hip Arthroscopy: Comparing Lumbar Plexus Versus Peri-capsular Injection

Nerve Block Clinical Trial

Official title:

Prospective, Single Blind Randomzied Controlled Trial Comparing Lumbar Plexus Peripheral Nerve Block Versus Peri-capsular Injection for Hip Arthroscopy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03244631
• Other study ID #: 20171307
• Status: Completed
• Phase: N/A
• Start date: September 26, 2017
• Est. completion date: February 1, 2020

Study information

• Verified date: February 2020
• Source: Washington Orthopaedics and Sports Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Comparison of lumbar plexus nerve block versus pericapsular injection for pain control during hip arthroscopy

Description:

The purpose of this study is to compare two different methods of pain control during and after hip arthroscopy surgery. It is not clear which of many different pain control methods are ideal to reduce pain for patients; consequently, the investigators are performing this study to compare the two main choices for pain control commonly used in order to identify if either is superior to the other.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 64
• Est. completion date: February 1, 2020
• Est. primary completion date: September 1, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 25 Years to 60 Years

Eligibility

Inclusion Criteria:

1. Patient scheduled to undergo hip arthroscopy with Dr. Wolff

2. Patient age between 25 and 60 years of age.

Exclusion Criteria:

1. Patient has known allergy to ropivicaine or morphine.

2. Patient unable to speak/read English (No translators available in clinic site).

3. Pregnant female.

4. Patient has a pre-operative narcotic use for hip pain

5. Patient has pre-existing chronic pain disorder (i.e. fibromyalgia)

Related Conditions & MeSH terms

• Hip Arthroscopy
• Nerve Block

Intervention

Procedure:
• Lumbar Plexus BLock
Peripheral nerve block
• Pericapsular injection
Injection around the area undergoing surgery

Locations

Country	Name	City	State
United States	Washington Orthopedics and Sports Medicine	Chevy Chase	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
Washington Orthopaedics and Sports Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain score	Compare post-operative pain scores in the immediate post-operative period as defined by visual-analog pain scale at the time point of one hour spent in the post-anesthesia care unit (PACU).	At the one hour point in the PACU
Secondary	Morphine equivalents	Compare the total morphine equivalents of opioids provided in the PACU within the first two hours of time spent in the PACU	At the two hour point in the PACU
Secondary	Time spent in PACU	Compare the overall time spent in the PACU as defined by time to arrival to time to discharge vitals.	Immediately after surgery